provider review and, if eligible, a prescription
Tirzepatide 5 mg showed an average weight loss of more than 5% of body weight at the median time of 16 weeks, while 10 and 15 mg took 12.4 weeks to show significant weight changes and glycemic control
Philip Rabito, M.D., a specialist in endocrinology, weight loss and wellness in New York City, also shared that "exciting" advancements lie ahead for weight-loss drugs, including GLP-1s and GIPs
For individuals with diabetes, the consumption of aspartame and other artificial sweeteners has been associated with a higher risk of colorectal and stomach cancer, though no overall link was found between artificial sweeteners and cancer in the general population
These findings were further confirmed by immunohistochemical analysis (55)
The appropriate retatrutide dose balances efficacy with tolerability across all side effect domains, not just heart rate